Neonatal hyperbilirubinemia is a common disease among newborns. In
clinical, the neonatal jaundice needs to be observed dynamically so
as to be found and treated in time. But the repeated abstraction of
blood sample for analysis would not only bring the neonates to more
annoyance, but also increase the workload and difficulties of
doctors and nurses, and it is unable to be accepted by the
patents.
Now we produced a non-invasive transcutaneous jaundice detector by
absorbing the worldadvanced technology and in-novating
continually.
